SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 1.91 |
| Enterprise Value ($M) | -3.75 |
| Book Value ($M) | 4.57 |
| Book Value / Share | 3.20 |
| Price / Book | 0.42 |
| NCAV ($M) | 2.22 |
| NCAV / Share | 1.56 |
| Price / NCAV | 0.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -5.88 |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.41 |
| Current Ratio | 1.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.61 |
| Assets | 9.97 |
| Liabilities | 5.40 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Halo Collective Inc. | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 50,246 | 120,865 | 41.57 | |
| 14,958 | 37,512 | 39.88 | |
| 4,306 | 22,028 | 19.55 | |
| 15,706 | 57,981 | 27.09 | |
| 40,197 | 116,212 | 34.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADVM – Adverum Biotechnologies, Inc. | AGEN – Agenus Inc. |
| AIMD – Ainos, Inc. | AKBA – Akebia Therapeutics, Inc. |
| ALBT – Avalon GloboCare Corp. |
Financial data and stock pages provided by
Fintel.io